Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Machacek

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|December 24, 2002
Photogrammetric and image processing aspects in quantitative flow visualizationMatthias Machacek, Thomas Rosgen
Plos Computational Biology|October 2, 2020
Modeling the activation of the alternative complement pathway and its effects on hemolysis in health and diseaseAntonello Caruso, Jannik Vollmer, Matthias Machacek, et al.
Molecular Pharmaceutics|July 21, 2025
A Semimechanistic Ocular Pharmacokinetic Model for ADVM-022 Gene Therapy Describing the Dose-Exposure Relationship in Monkeys and the Scaling to HumanFlorian Hugi, Jannik Vollmer, Lionel Renaud, et al.
Experimental Cell Research|April 22, 2010
Protrusion and actin assembly are coupled to the organization of lamellar contractile structuresJames I Lim, Mohsen Sabouri-Ghomi, Matthias Machacek, et al.
Frontiers in Neuroscience|July 18, 2024
NfL concentration in CSF is a quantitative marker of the rate of neurodegeneration in aging and Huntington's disease: a semi-mechanistic model-based analysisMatthias Machacek, Elena Garcia-Montoya, Peter McColgan, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 21, 2024
Intrathecal administration of Anti-Nogo-A antibody in macaque monkeys: Pharmacokinetics, tissue penetration and target interactionPascal B Kunz, Michael A Maurer, Jannik Vollmer, et al.
Journal of Clinical Pharmacology|June 6, 2020
Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen-Induced Platelet AggregationLionel Renaud, Kristell Lebozec, Christine Voors-Pette, et al.
Science Signaling|July 6, 2012
Quantitative imaging of epithelial cell scattering identifies specific inhibitors of cell motility and cell-cell dissociationDinah Loerke, Quint le Duc, Iris Blonk, et al.
Nature Cell Biology|May 17, 2011
Protein kinase A governs a RhoA-RhoGDI protrusion-retraction pacemaker in migrating cellsEugene Tkachenko, Mohsen Sabouri-Ghomi, Olivier Pertz, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2020
Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection ModelFabian Bernhard, Rajesh Odedra, Sylvie Sordello, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|December 24, 2002
Photogrammetric and image processing aspects in quantitative flow visualizationMatthias Machacek, Thomas Rosgen
Plos Computational Biology|October 2, 2020
Modeling the activation of the alternative complement pathway and its effects on hemolysis in health and diseaseAntonello Caruso, Jannik Vollmer, Matthias Machacek, et al.
Molecular Pharmaceutics|July 21, 2025
A Semimechanistic Ocular Pharmacokinetic Model for ADVM-022 Gene Therapy Describing the Dose-Exposure Relationship in Monkeys and the Scaling to HumanFlorian Hugi, Jannik Vollmer, Lionel Renaud, et al.
Experimental Cell Research|April 22, 2010
Protrusion and actin assembly are coupled to the organization of lamellar contractile structuresJames I Lim, Mohsen Sabouri-Ghomi, Matthias Machacek, et al.
Frontiers in Neuroscience|July 18, 2024
NfL concentration in CSF is a quantitative marker of the rate of neurodegeneration in aging and Huntington's disease: a semi-mechanistic model-based analysisMatthias Machacek, Elena Garcia-Montoya, Peter McColgan, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 21, 2024
Intrathecal administration of Anti-Nogo-A antibody in macaque monkeys: Pharmacokinetics, tissue penetration and target interactionPascal B Kunz, Michael A Maurer, Jannik Vollmer, et al.
Journal of Clinical Pharmacology|June 6, 2020
Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen-Induced Platelet AggregationLionel Renaud, Kristell Lebozec, Christine Voors-Pette, et al.
Science Signaling|July 6, 2012
Quantitative imaging of epithelial cell scattering identifies specific inhibitors of cell motility and cell-cell dissociationDinah Loerke, Quint le Duc, Iris Blonk, et al.
Nature Cell Biology|May 17, 2011
Protein kinase A governs a RhoA-RhoGDI protrusion-retraction pacemaker in migrating cellsEugene Tkachenko, Mohsen Sabouri-Ghomi, Olivier Pertz, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2020
Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection ModelFabian Bernhard, Rajesh Odedra, Sylvie Sordello, et al.
Pageof 2